A detailed history of Detalus Advisors, LLC transactions in Elevance Health, Inc. stock. As of the latest transaction made, Detalus Advisors, LLC holds 1,807 shares of ELV stock, worth $711,506. This represents 0.33% of its overall portfolio holdings.

Number of Shares
1,807
Previous 1,807 -0.0%
Holding current value
$711,506
Previous $979,000 4.09%
% of portfolio
0.33%
Previous 0.35%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$497.49 - $547.8 $76,613 - $84,361
154 Added 9.32%
1,807 $979,000
Q4 2023

Jan 24, 2024

BUY
$433.51 - $488.06 $15,606 - $17,570
36 Added 2.23%
1,653 $779,000
Q3 2023

Oct 26, 2023

BUY
$414.13 - $475.93 $1,656 - $1,903
4 Added 0.25%
1,617 $704,000
Q2 2023

Jul 28, 2023

BUY
$436.33 - $496.2 $19,634 - $22,329
45 Added 2.87%
1,613 $716,000
Q1 2023

May 15, 2023

BUY
$446.3 - $502.2 $699,798 - $787,449
1,568 New
1,568 $720,000

Others Institutions Holding ELV

About Elevance Health, Inc.


  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $94.5B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track Detalus Advisors, LLC Portfolio

Follow Detalus Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Detalus Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Detalus Advisors, LLC with notifications on news.